Negative: What Does It Mean To Have A Test Result?
Negative: What Does It Mean To Have A Test Result?
Negative: What Does It Mean To Have A Test Result?
NEGATIVE
A negative result for this test means that SARS-CoV-2 RNA (the cause of
COVID-19) was not detected in the collected sample.
A negative test result does not completely rule out being infected with COVID-19.
If you test negative for COVID-19, this means the virus was not detected at the time your
specimen was collected. It is still possible that you were very early in your infection at the time of
your specimen collection and that you could test positive later.
Also, you could be exposed later and still develop the illness. For all these reasons, it is
important to follow CDC guidance, including but not limited to frequent hand washing, social
distancing, wearing a face covering, covering coughs and sneezes, monitoring symptoms, and
cleaning and disinfectant of frequently touched surfaces - even after a negative test result.
Test information
Provider
WILDEY DENNEL
NEGATIVE
A negative result for this test means that SARS-CoV-2 RNA (the cause of
COVID-19) was not detected in the collected sample.
Legal Disclaimer
Negative: SARS-CoV-2 not detected Testing did not identify the presence of SARS-CoV-2 (the virus that causes
COVID-19) in the patient's sample. Many factors can impact the sensitivity of this test, including variability in sample
collection technique, stage of infection, or the presence of interfering substances. Collection of multiple samples may
be necessary to detect the SARS-CoV-2 virus. If clinically indicated, consider collecting a new sample for COVID-19
testing or testing for other respiratory viruses. This test was developed for the detection of nucleic acids from the
SARS-CoV-2 virus by RT-PCR in individuals who meet SARS-CoV-2 clinical and/or epidemiological criteria. This test
has not been FDA cleared or approved. This test has been authorized by FDA under an EUA for use by the
authorized laboratory. This test is only authorized for the duration of time that the Secretary of the HHS declares
circumstances exist justifying the authorization of the emergency use of in vitro diagnostic tests for detection of
SARS-CoV-2 virus and/or diagnosis of COVID-19 infection under section 564(b)(1) of the Act, 21 U.S.C.
360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. To learn more about this test, go to https://
www.helix.com/pages/covid19-efforts Performed by: Helix, CAP 9382893, CLIA 05D2117342, 9875 Towne Centre Dr
Suite 100 San Diego, CA 92121 Laboratory Director: Philip D Cotter, PhD, FACMG, FFSC (RCPA) Performed by:
Helix, CLIA 05D2197032, 6925 Lusk Boulevard San Diego, CA 92121, Michael J. Bauer, MD